EDEN TEDLA: Open Payments
NPI 1013437342 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 31 payments from 9 companies in 2025. Trend: 2023 $2,063 · 2024 $1,475 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $113 |
| PFIZER INC. | 4 | $78 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: JARDIANCE, XIFAXAN, TEFLARO, DALVANCE, ELIQUIS, ZERBAXA, LifeVest, GIVLAARI.
Industry payments across NC — which companies pay providers there.
